Chrysin: Difference between revisions
Appearance
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII'). |
Citation bot (talk | contribs) Add: doi-access, s2cid. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox3 | #UCB_webform_linked 392/1975 |
||
(160 intermediate revisions by 51 users not shown) | |||
Line 1: | Line 1: | ||
{{chembox |
{{chembox |
||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
| Watchedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 443522809 |
||
| |
| Name = Chrysin |
||
| |
| ImageFile = Chrysin.svg |
||
| |
| ImageName = Chrysin |
||
| |
| ImageFile1 = Chrysin molecule ball.png |
||
| ImageSize1 = 220 |
|||
| IUPACName = 5,7-dihydroxy-2-phenyl-4H-chromen-4-one |
|||
| ImageAlt1 = Ball-and-stick model of chrysin |
|||
| OtherNames = 5,7-dihydroxyflavone, Chrysin, 5,7-dihydroxy-2-phenyl-(9CI), NP-005901, galangin flavanone |
|||
| IUPACName = 5,7-Dihydroxyflavone |
|||
⚫ | |||
| SystematicName = 5,7-Dihydroxy-2-phenyl-4''H''-1-benzopyran-4-one |
|||
⚫ | |||
| OtherNames = NP-005901; Galangin flavanone |
|||
⚫ | |||
⚫ | |||
| ChemSpiderID = 4444926 |
| ChemSpiderID = 4444926 |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = C10028 |
| KEGG = C10028 |
||
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|||
| ChEBI = 75095 |
|||
| InChIKey = RTIXKCRFFJGDFG-UHFFFAOYAO |
| InChIKey = RTIXKCRFFJGDFG-UHFFFAOYAO |
||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
Line 22: | Line 28: | ||
| CASNo_Ref = {{cascite|correct|CAS}} |
| CASNo_Ref = {{cascite|correct|CAS}} |
||
| CASNo= 480-40-0 |
| CASNo= 480-40-0 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| |
| UNII = 3CN01F5ZJ5 |
||
| SMILES = O=C\1c3c(O/C(=C/1)c2ccccc2)cc(O)cc3O |
| SMILES = O=C\1c3c(O/C(=C/1)c2ccccc2)cc(O)cc3O |
||
| |
| PubChem = 5281607 |
||
| |
| InChI = 1/C15H10O4/c16-10-6-11(17)15-12(18)8-13 |
||
(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H |
(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H |
||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
| |
| C=15 | H=10 | O=4 |
||
| |
| Density = |
||
| |
| MeltingPt = |
||
⚫ | |||
| ExactMass = 254.057909 g mol<sup>−1</sup> |
|||
| Density = |
|||
| MeltingPt = |
|||
⚫ | |||
}} |
}} |
||
}} |
}} |
||
'''Chrysin''', also called '''5,7-dihydroxyflavone''',<ref name=PubChem/> is a [[flavone]] found in [[honey]], [[propolis]], the [[passion flower]]s, ''[[Passiflora caerulea]]'' and ''[[Passiflora incarnata]]'', and in ''[[Oroxylum indicum]]''.<ref name=Brahmachari2017/> It is [[extract]]ed from various plants, such as the blue passion flower (''Passiflora caerulea'').<ref name=PubChem/> Following oral intake by humans, chrysin has low [[bioavailability]] and rapid [[excretion]].<ref name=PubChem/> It is under [[basic research]] to evaluate its safety and potential [[function (biology)|biological effects]].<ref name=PubChem/> |
|||
'''Chrysin''' is a naturally occurring [[flavone]] chemically extracted from the blue [[passion flower]] (''[[Passiflora caerulea]]''). Honeycomb also contains small amounts. It is also reported in ''[[Oroxylum indicum]]'' or Indian trumpetflower. |
|||
Chrysin is an ingredient in [[dietary supplement]]s.{{sfn|FDA|2016|p=3}} As of 2016, there was no clinical use of chrysin,<ref name=PubChem/> and no evidence for its effect on [[testosterone]] levels.{{sfn|FDA|2016|p=8}} In 2016, the US [[Food and Drug Administration]] did not recommend chrysin be included on the list of bulk drug substances that can be used in [[compounding]] under section 503A of the [[Federal Food, Drug, and Cosmetic Act]].{{sfn|FDA|2016|p=13}} |
|||
==Aromatase inhibition== |
|||
Advertised as an [[aromatase]] inhibitor supplement by bodybuilders and athletes.<ref>{{cite journal |author=van Meeuwen JA, Korthagen N, de Jong PC, Piersma AH, van den Berg M. |title=(Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture |journal=Toxicol Appl Pharmacol. |year=2007 |pmid=17482226 |volume=221 |issue=3 |pages=372–83 |doi=10.1016/j.taap.2007.03.016}}</ref><ref>{{cite journal |author=Kellis JT Jr, Vickery LE. |title=Inhibition of human estrogen synthetase (aromatase) by flavones |journal=Science |year=1984 |pmid=6474163 |doi=10.1126/science.6474163 |volume=225 |pages=1032 |issue=4666}}</ref> However, studies done [[in vivo]] show that orally administered chrysin does not have clinical [[aromatase inhibitor]] activity.<ref>{{cite journal |author=Saarinen N, Joshi SC, Ahotupa M, Li X, Ammälä J, Mäkelä S, Santti R. |title=No evidence for the in vivo activity of aromatase-inhibiting flavonoids |journal=J Steroid Biochem Mol Biol. |year=2001 |pmid=11595503 |doi=10.1016/S0960-0760(01)00098-X |volume=78 |pages=231 |issue=3}}</ref><ref>{{cite journal |author=Int J Sport Nutr Exerc Metab. |title=Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men |journal=Int J Sport Nutr Exerc Metab. |year=2000 |pmid=10997957 |volume=10 |issue=3 |pages=340–59}}</ref> This has led to some practitioners administering the drug transdermally(through the skin). |
|||
== Occurrence == |
|||
Since chrysin is available as an herbal supplement, some users, for instance body builders, are taking chrysin with the hope of raising testosterone levels or stimulating testosterone production. One study listed below did not find chrysin supplementation to lead to any significant increase in testosterone production. |
|||
A component in various [[medicinal plants]] (e.g. ''[[Scutellaria baicalensis]]''), chrysin is a [[dihydroxyflavone]], a type of [[flavonoid]].<ref name=SamarghandianFarkhondeh2017/> It is also found in [[honey]], [[propolis]], the [[passion flower]]s, ''[[Passiflora caerulea]]'' and ''[[Passiflora incarnata]]'', in ''[[Oroxylum indicum]]'',<ref name=Brahmachari2017>{{cite book| editor-first = Goutam | editor-last = Brahmachari | title = Discovery and Development of Neuroprotective Agents from Natural Products | chapter = Chapter 2 – Natural Phytoestrogens: A Class of Promising Neuroprotective Agents for Parkinson Disease | first1 = Marc | last1 = Morissette | first2 = Nadhir | last2 = Litim | first3 = Thérèse | last3 = Di Paolo | name-list-style = vanc | chapter-url = https://books.google.com/books?id=LzVHDgAAQBAJ&pg=PA32| date = 18 May 2017 | publisher=Elsevier Science | isbn = 978-0-12-809769-4 | pages = 32 | doi = 10.1016/B978-0-12-809593-5.00002-1 }}</ref> carrots,<ref name=PubChem/> [[chamomile]],<ref name=ZhandiAnsari2017>{{cite journal|last1=Zhandi|first1=M|last2=Ansari|first2=M|last3=Roknabadi|first3=P|last4=Zare Shahneh|first4=A|last5=Sharafi|first5=M|title=Orally administered Chrysin improves post-thawed sperm quality and fertility of rooster|journal=Reproduction in Domestic Animals|volume=52|issue=6|year=2017|pages=1004–1010|issn=0936-6768|doi=10.1111/rda.13014|pmid=28695606|s2cid=28744455}}</ref> many fruits, and in [[mushroom]]s, such as the mushroom ''[[Pleurotus ostreatus]]''.<ref name=SamarghandianFarkhondeh2017/> It is [[extract]]ed from various plants,<ref name=PubChem/> such as the blue passion flower (''Passiflora caerulea'').<ref name=PubChem>{{cite web|title=Chrysin: Compound Summary for CID 5281607|url=https://pubchem.ncbi.nlm.nih.gov/compound/chrysin#section=Top|publisher=PubChem, National Center for Biotechnology Information, US National Institutes of Health|date=14 July 2018}}</ref> |
|||
Chrysin was once believed to be an effective aromatase inhibitor, decreasing the levels of estrogen in the body. However, there is growing consensus that chrysin has no effect on estrogen levels in either animals or humans.<ref>Dean, W.Chrysin: Is It An Effective Aromatase Inhibitor? http://www.vrp.com/articles.aspx?page=LIST&ProdID=1208&qid=&zTYPE=2</ref> Early evidence was reported in the early 1980s through in vitro studies (in the laboratory, as opposed to in the body).<ref>{{cite journal |author=Kellis JT, Vickery LE |title=Inhibition of human estrogen synthetase (aromatase) by flavones |journal=Science |volume=225 |issue=4666 |pages=1032–4 |year=1984 |month=September |pmid=6474163 |url=http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=6474163 |doi=10.1126/science.6474163}}</ref><ref>{{cite journal |author=Ibrahim AR, Abul-Hajj YJ |title=Aromatase inhibition by flavonoids |journal=J. Steroid Biochem. Mol. Biol. |volume=37 |issue=2 |pages=257–60 |year=1990 |month=October |pmid=2268557 |doi=10.1016/0960-0760(90)90335-I }}</ref><ref>{{cite journal |author=Campbell DR, Kurzer MS |title=Flavonoid inhibition of aromatase enzyme activity in human preadipocytes |journal=J. Steroid Biochem. Mol. Biol. |volume=46 |issue=3 |pages=381–8 |year=1993 |month=September |pmid=9831487 |doi=10.1016/0960-0760(93)90228-O }}</ref><ref>{{cite journal |author=Wang C, Mäkelä T, Hase T, Adlercreutz H, Kurzer MS |title=Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes |journal=J. Steroid Biochem. Mol. Biol. |volume=50 |issue=3-4 |pages=205–12 |year=1994 |month=August |pmid=8049151 |doi=10.1016/0960-0760(94)90030-2 }}</ref><ref>{{cite journal |author=Pelissero C, Lenczowski MJ, Chinzi D, Davail-Cuisset B, Sumpter JP, Fostier A |title=Effects of flavonoids on aromatase activity, an in vitro study |journal=J. Steroid Biochem. Mol. Biol. |volume=57 |issue=3-4 |pages=215–23 |year=1996 |month=February |pmid=8645631 |url=http://linkinghub.elsevier.com/retrieve/pii/0960-0760(95)00261-8 |doi=10.1016/0960-0760(95)00261-8}}</ref><ref>{{cite journal |author=Le Bail JC, Laroche T, Marre-Fournier F, Habrioux G |title=Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids |journal=Cancer Lett. |volume=133 |issue=1 |pages=101–6 |year=1998 |month=November |pmid=9929167 |url=http://linkinghub.elsevier.com/retrieve/pii/S0304-3835(98)00211-0 |doi=10.1016/S0304-3835(98)00211-0}}</ref><ref>{{cite journal |author=Jeong HJ, Shin YG, Kim IH, Pezzuto JM |title=Inhibition of aromatase activity by flavonoids |journal=Arch. Pharm. Res. |volume=22 |issue=3 |pages=309–12 |year=1999 |month=June |pmid=10403137 |doi=10.1007/BF02976369 }}</ref> Unfortunately, follow-up studies determined that cell membranes effectively block chrysin from entering the cells and having any effect at all on estrogen levels in biological organisms.<ref>{{cite journal |author=Campbell DR, Kurzer MS |title=Flavonoid inhibition of aromatase enzyme activity in human preadipocytes |journal=J. Steroid Biochem. Mol. Biol. |volume=46 |issue=3 |pages=381–8 |year=1993 |month=September |pmid=9831487 |doi=10.1016/0960-0760(93)90228-O }}</ref><ref>{{cite journal |author=King DS, Sharp RL, Vukovich MD, ''et al.'' |title=Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial |journal=JAMA |volume=281 |issue=21 |pages=2020–8 |year=1999 |month=June |pmid=10359391 |url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=10359391 |doi=10.1001/jama.281.21.2020}}> [see comments]</ref><ref>{{cite journal |author=Saarinen N, Joshi SC, Ahotupa M, Li X, Ammälä J, Mäkelä S, Santti R. |title=No evidence for the in vivo activity of aromatase-inhibiting flavonoids |journal=J Steroid Biochem Mol Biol. |year=2001 |pmid=11595503 |doi=10.1016/S0960-0760(01)00098-X |volume=78 |pages=231 |issue=3}}</ref> In vivo (in the body) studies involving biological organisms lend support to the observation that chrysin has no effect on estrogen levels, but may have other detrimental effects to the body, particularly to thyroid function.<ref>{{cite journal |author=Koehrle J, Auf'mkolk M, Spanka M, Irmscher K, Cody V, Hesch RD |title=Iodothyronine deiodinase is inhibited by plant flavonoids |journal=Prog. Clin. Biol. Res. |volume=213 |pages=359–71 |year=1986 |pmid=3086894 }}</ref> For instance, a 30 day study administered chrysin to four groups of mice both orally and via injection to examine chrysin's effect on serum estrogen levels. The results showed that chrysin had no effect on estrogen levels. Further, the mice treated with chrysin became considerably fatter, possibly due to chrysin's ability to disrupt thyroid function.<ref>Shibayama, J. The Oral Bioavailability and In Vivo Activity of Chrysin in Exercising and Non-Exercising Mice. Submitted for publication, as reported by VRP article (by W. Dean)</ref> Another study on rats administered 50 mg of chrysin per kg body weight, considerably more than found in dietary supplements. Chrysin was found to have no ability to inhibit aromatase, possibly due to poor absorption or bioavailability.<ref>{{cite journal |author=Saarinen N, Joshi SC, Ahotupa M, Li X, Ammälä J, Mäkelä S, Santti R. |title=No evidence for the in vivo activity of aromatase-inhibiting flavonoids |journal=J Steroid Biochem Mol Biol. |year=2001 |pmid=11595503 |doi=10.1016/S0960-0760(01)00098-X |volume=78 |pages=231 |issue=3}}</ref> |
|||
The amount of chrysin in honey from various plant sources is about 0.2 mg per 100 g.<ref name=IstasseJacquet2016>{{cite journal | vauthors = Istasse T, Jacquet N, Berchem T, Haubruge E, Nguyen BK, Richel A | title = Extraction of Honey Polyphenols: Method Development and Evidence of Cis Isomerization | journal = Analytical Chemistry Insights | volume = 11 | pages = 49–57 | year = 2016 | pmid = 27547032 | pmc = 4981221 | doi = 10.4137/ACI.S39739 }}</ref> Chrysin is typically found at higher amounts in propolis than in honey.<ref name=PremratanachaiChanchao2014>{{cite journal | vauthors = Premratanachai P, Chanchao C | title = Review of the anticancer activities of bee products | journal = Asian Pacific Journal of Tropical Biomedicine | volume = 4 | issue = 5 | pages = 337–44 | year = 2014 | pmid = 25182716 | pmc = 3985046 | doi = 10.12980/APJTB.4.2014C1262 }}</ref> A 2010 study found the amount of chrysin was 0.10 mg/kg in honeydew honey, and 5.3 mg/kg in forest honeys.<ref name=Nabavi2015>{{cite journal | vauthors = Nabavi SF, Braidy N, Habtemariam S, Orhan IE, Daglia M, Manayi A, Gortzi O, Nabavi SM | title = Neuroprotective effects of chrysin: From chemistry to medicine | journal = Neurochemistry International | volume = 90 | pages = 224–31 | year = 2015 | pmid = 26386393 | doi = 10.1016/j.neuint.2015.09.006 | s2cid = 24391203 }}</ref> A 2010 study found the amount of chrysin in propolis was as much as 28 g/L.<ref name=Nabavi2015/> A 2013 study found the amount of chrysin in various mushrooms from the island of Lesvos, Greece, varied between 0.17 mg/kg in ''[[Lactarius deliciosus]]'' to 0.34 mg/kg in ''[[Suillus bellinii]]''.<ref name=Nabavi2015/> |
|||
==Pharmacokinetics== |
|||
* Peak plasma chrysin concentrations after oral dose of 400 mg = 3–16 ng mL−1 <ref name="Waile">{{cite journal |author=Walle T, Otake Y, Brubaker JA, Walle UK, Halushka PV |title=Disposition and metabolism of the flavonoid chrysin in normal volunteers |journal=Br J Clin Pharmacol |volume=51 |issue=2 |pages=143–6 |year=2001 |month=February |pmid=11259985 |pmc=2014445 }}</ref> |
|||
* AUC = 5–193 ng mL−1 h <ref name="Waile" /> |
|||
* Plasma chrysin sulfate concentrations were 30-fold higher (AUC 450–4220 ng mL−1 h).<ref name="Waile" /> |
|||
* Excretion: urine peak concentration = 0.2–3.1 mg. Most of the dose appeared in faeces as chrysin.<ref name="Waile" /> |
|||
== Bioavailability == |
|||
==Inflammation== |
|||
Chrysin has been shown to induce an anti-inflammatory effect, most likely by inhibition of COX-2 expression and via IL-6 signaling.<ref>{{cite journal |author=Woo KJ, Jeong YJ, Inoue H, Park JW, Kwon TK |title=Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity |journal=FEBS Lett. |volume=579 |issue=3 |pages=705–11 |year=2005 |month=January |pmid=15670832 |doi=10.1016/j.febslet.2004.12.048 }}</ref> |
|||
The effects of chrysin are reliant on its [[bioavailability]] and [[solubility]].<ref name=Nabavi2015/> Following oral intake by humans, chrysin has low bioavailability and rapid [[excretion]].<ref name=PubChem/> As a result, it is poorly absorbed.<ref name=PubChem/> |
|||
==Anxiety== |
|||
In rodent in vivo studies, chrysin was found anxiolytic.<ref>{{cite journal |author=Brown E, Hurd NS, McCall S, Ceremuga TE |title=Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat |journal=AANA J |volume=75 |issue=5 |pages=333–7 |year=2007 |month=October |pmid=17966676 }}</ref><ref>{{cite journal |author=Wolfman C, Viola H, Paladini A, Dajas F, Medina JH |title=Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea |journal=Pharmacol. Biochem. Behav. |volume=47 |issue=1 |pages=1–4 |year=1994 |month=January |pmid=7906886 |doi=10.1016/0091-3057(94)90103-1 }}</ref> |
|||
A 1998 study determined that the highest amounts in [[blood plasma|plasma]] was from 12 to 64 nM.<ref name=Nabavi2015/> As of 2015, the [[serum (blood)|serum]] levels of chrysin have not been cited in the literature.<ref name=Nabavi2015/> Following oral intake by humans, the bioavailability was reported to be from 0.003% to 0.02%.<ref name=Nabavi2015/> |
|||
In herbal medicine, chrysin is recommended as a remedy for anxiety,<ref>{{cite book |author=Balch, Phyllis A. |title=Prescription for herbal healing: [an easy-to-use A-to-Z reference to hundreds of common disorders and their herbal remedies] |publisher=Avery |location=New York |year=2002 |isbn=0-89529-869-4 }}</ref> but there are no controlled data in humans available. |
|||
== Oral and topical application == |
|||
Many herbal remedies that contain chrysin promote their value as a libido-increasing supplement. There is some in-vivo evidence for chrysin's libido-enhancing effects in rats.<ref>{{cite journal |author=Dhawan K, Kumar S, Sharma A |title=Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats |journal=J Med Food |volume=5 |issue=1 |pages=43–8 |year=2002 |pmid=12511112 |doi=10.1089/109662002753723214 }}</ref> |
|||
There is insufficient information to determine how long chrysin has been used in pharmacy [[compounding]].{{sfn|FDA|2016|p=11}} Chrysin is used as an ingredient in [[dietary supplement]]s, but there is no information on systemic exposure from [[topical medication|topical application]].{{sfn|FDA|2016|p=3}} As of 2016, there was no evidence to support any effect of oral chrysin on [[testosterone]] levels,{{sfn|FDA|2016|p=8}} or an any disease-modifying activity with oral or topical formulations.{{sfn|FDA|2016|p=9}} |
|||
Chrysin demonstrated cell toxicity and inhibition of DNA synthesis at very low concentrations in a normal trout liver cell line.<ref>{{cite journal |author=Tsuji PA, Walle T. |title=Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line |journal=[[Chem Biol Interact]] |year=2008 |pmid=17884029 |doi=10.1016/j.cbi.2007.08.007 |volume=171 |pages=37 |issue=1 |pmc=2219546}}</ref> |
|||
== |
== Safety == |
||
{{reflist|2}} |
|||
A daily consumed amount of chrysin of 0.5 to 3 g is considered safe.<ref name=SamarghandianFarkhondeh2017>{{cite journal | vauthors = Samarghandian S, Farkhondeh T, Azimi-Nezhad M | title = Protective Effects of Chrysin Against Drugs and Toxic Agents | journal = Dose-response | volume = 15 | issue = 2 | pages = 1559325817711782 | year = 2017 | pmid = 28694744 | pmc = 5484430 | doi = 10.1177/1559325817711782 }}</ref> As of 2016, there was no toxicity attributable to chrysin in [[clinical trial]]s or [[adverse event]] reporting.{{sfn|FDA|2016|p=10}} As of 2016, clinical safety issues have not been identified.{{sfn|FDA|2016|p=12}} As of 2016, nonclinical data suggest potential concerns.{{sfn|FDA|2016|p=12}} In 2016, the US [[Food and Drug Administration]] did not recommend chrysin be included on the list of bulk drug substances that can be used in compounding under section 503A of the [[Federal Food, Drug, and Cosmetic Act]] based on consideration of the following criteria: (1) physicochemical characterization; (2) safety; (3) effectiveness; and (4) historical use of the substance in compounding.{{sfn|FDA|2016|p=13}} |
|||
{{Flavone}} |
|||
== Research == |
|||
As of 2016, there is no evidence for chrysin being used in human clinical applications.<ref name=PubChem/> Research showed that orally administered chrysin does not have clinical activity as an [[aromatase]] inhibitor.<ref name=PubChem/><ref name="Saarinen2001">{{cite journal | vauthors = Saarinen N, Joshi SC, Ahotupa M, Li X, Ammälä J, Mäkelä S, Santti R | title = No evidence for the in vivo activity of aromatase-inhibiting flavonoids | journal = The Journal of Steroid Biochemistry and Molecular Biology | volume = 78 | issue = 3 | pages = 231–9 | date = September 2001 | pmid = 11595503 | doi = 10.1016/S0960-0760(01)00098-X | s2cid = 25787862 }}</ref> |
|||
[[nanotechnology|Nanoformulations]] of [[polyphenol]]s, including chrysin, are made using various carrier methods, such as [[liposome]]s and [[nanocapsule]]s.<ref name=IJN2017>{{cite journal | vauthors = Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, Bahramsoltani R, Karimi-Soureh Z, Rahimi R, Abdollahi M | title = Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective | journal = International Journal of Nanomedicine | volume = 12 | pages = 2689–2702 | year = 2017 | pmid = 28435252 | pmc = 5388197 | doi = 10.2147/IJN.S131973 | doi-access = free }}</ref> |
|||
== Bibliography == |
|||
*{{cite web|url=https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM509958.pdf|title=Chrysin|last1=Brave|first1=Michael|name-list-style=vanc|publisher=Pharmacy Compounding Advisory Committee, Division of Oncology Products, US Food and Drug Administration|pages=1–13|date=23 June 2016|ref={{harvid|FDA|2016}}}}{{PD-notice}} |
|||
== References == |
|||
{{Reflist}} |
|||
{{Flavones}} |
|||
{{Xenobiotic-sensing receptor modulators}} |
|||
[[Category:Aromatase inhibitors]] |
|||
[[Category:Flavones]] |
[[Category:Flavones]] |
||
[[Category:Flavonoids found in Asteraceae]] |
|||
[[Category:Resorcinols]] |
[[Category:Resorcinols]] |
||
[[fr:Chrysine]] |
|||
[[pt:Crisina]] |